In order to estimate the heterogeneity, potential non-genetic confounders affecting CEA levels in healthy populations were analyzed in CRC patients at first and revealed that the status of lymph node metastasis was a significant contributor. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.